Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachectic cancer patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachectic cancer patients
Authors
Keywords
Oxycodone, Cancer cachexia, Interleukin-6, Pharmacokinetics, Central symptom, CYP3A4
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 72, Issue 12, Pages 1463-1470
Publisher
Springer Nature
Online
2016-08-26
DOI
10.1007/s00228-016-2116-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of cytokines on CYP3A4 expression and reversal of the effects by anti-cytokine agents in the three-dimensionally cultured human hepatoma cell line FLC-4
- (2015) Hanaka Mimura et al. Drug Metabolism and Pharmacokinetics
- A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease–Drug Interactions: Suppression of CYP3A by IL-6
- (2013) K K Machavaram et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cancer Cachexia Raises the Plasma Concentration of Oxymorphone Through the Reduction of CYP3A But Not CYP2D6 in Oxycodone-Treated Patients
- (2013) Takafumi Naito et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Cancer cachexia—pathophysiology and management
- (2013) Hajime Suzuki et al. JOURNAL OF GASTROENTEROLOGY
- Does the pharmacology of oxycodone justify its increasing use as an analgesic?
- (2013) Klaus T. Olkkola et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients
- (2012) Takafumi Naito et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Evidence-Based Treatment of Delirium in Patients With Cancer
- (2012) William Breitbart et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease–Drug–Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis
- (2011) C Schmitt et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of Interleukin-6 (IL-6) and an Anti-IL-6 Monoclonal Antibody on Drug-Metabolizing Enzymes in Human Hepatocyte Culture
- (2011) L. J. Dickmann et al. DRUG METABOLISM AND DISPOSITION
- Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
- (2011) Trine Naalsund Andreassen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP3A5*3 Affects Plasma Disposition of Noroxycodone and Dose Escalation in Cancer Patients Receiving Oxycodone
- (2011) Takafumi Naito et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pain, Depression, and Fatigue as a Symptom Cluster in Advanced Cancer
- (2011) Barry J.A. Laird et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone
- (2010) CF Samer et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Correlation between Increased Serum Concentrations of Interleukin-6 Family Cytokines and Disease Activity in Rheumatoid Arthritis Patients
- (2010) Soo-Jin Chung et al. YONSEI MEDICAL JOURNAL
- Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics
- (2009) ET Morgan CLINICAL PHARMACOLOGY & THERAPEUTICS
- Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer
- (2008) E. T. Morgan et al. DRUG METABOLISM AND DISPOSITION
- An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
- (2008) Donald C. McMillan PROCEEDINGS OF THE NUTRITION SOCIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More